AI alone is not a sufficient investment strategy, according to Petra Cihlářová of JSK Investments. She emphasizes that companies like Andromeda Surgical, which focus on autonomous surgical platforms, must address critical issues such as surgeon shortages, regulatory hurdles, and the need for clinical evidence to prove their value. These factors are essential for demonstrating a strong return on investment in the MedTech and HealthTech sectors. AI
IMPACT Highlights the need for AI-driven companies to demonstrate tangible value beyond the technology itself to attract investment.
RANK_REASON Opinion piece from an investment director discussing investment theses related to AI in healthcare.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →